As a new class of OADs, DPP-4 inhibitors have many important advantages over other currently available antidiabetic drugs. Compared with currently available insulin secretagogues, DPP-4 inhibitors, by ...
Among India's 89.8 million people with T2D [1], heart failure incidence reaches approximately 50%, with 33% higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results